stockrowAlcon
ALC Healthcare Medical Instruments & Supplies
Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.
- Revenue
- +8.74%
- EPS
- −100.0%
- Free cash flow
- −0.54%
- Total debt
- −0.55%
Quarter to June 2026, against a year earlier
Follow ALC
Alert me
Alcon (ALC) P/S ratio
As of 5 November 2026, Alcon (ALC) trades at a P/S ratio of 3.4×. Over the past ten years it has ranged from 0.0× (June 2019) to 5.5× (September 2021); the current reading is higher than 25% of that period. That is above the Medical Instruments & Supplies industry median of 2.5× and in line with the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 3.7× | (11.75%) |
| FY2024 | 4.2× | 5.42% |
| FY2023 | 4.0× | 3.30% |
| FY2022 | 3.9× | (24.48%) |
| FY2021 | 5.1× | 9.04% |
| FY2020 | 4.7× | 28.37% |
| FY2019 | 3.7× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 3.0× | (12.90%) |
| Mar 2026 | 3.5× | (7.62%) |
| Dec 2025 | 3.7× | 3.58% |
| Sep 2025 | 3.6× | (17.26%) |
| 28 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| BAX Baxter International Inc. compare | 1.1× |
| MDLN Medline Inc. compare | 1.1× |
| SOLV Solventum Corporation compare | 1.8× |
| ALGN Align Technology, Inc. compare | 2.7× |
| BDX Becton, Dickinson and Company compare | 2.8× |
| COO The Cooper Companies, Inc. compare | 2.9× |
| ALC Alcon | 3.4× |
| RMD ResMed Inc. compare | 6.0× |
| WST West Pharmaceutical Services, Inc. compare | 8.1× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on ALC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement